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Abstract
The behavioral mechanisms underlying antipsychotic-induced maternal behavior deficits were examined in the present study.
Different groups of postpartum rats were treated with haloperidol (0.1 mg/kg), clozapine (10.0 mg/kg), chlordiazepoxide (5.0
mg/kg, an anxiolytic) or vehicle (0.9% saline) on Days 4 and 6 postpartum and their maternal behaviors were tested under either
pup-separation (e.g. pups were removed from their mothers for 4 h before testing) or no-pup-separation condition. Maternal
behavior and drug-induced sedation were further tested for 3 days from Day 8 to 12 postpartum. Results show that pup-separation, which putatively increases maternal motivation, did significantly shorten clozapine-elongated pup approach latency,
increase pup licking and nursing but fail to reverse the deficits in pup retrieval and nest building in the lactating rats treated with
haloperidol and clozapine. Repeated haloperidol treatment produced a progressively enhanced disruption on pup retrieval and
nest building and an attenuated sedation. In contrast, clozapine showed a progressively diminished disruption on pup retrieval
and a concomitantly diminished sedative effect. Based on these findings, we suggest that antipsychotic drugs disrupt active
maternal responses at least in part by suppressing maternal motivation, and drug-induced sedation also contributes to this disruptive effect, especially with clozapine.

1. Introduction
Clinical work on the mother-child relationship shows that the
quality of maternal care from mothers with schizophrenia is generally inferior to that from healthy mothers and mothers with affective disorders (Bosanac et al., 2003; Wan et al., 2007). In comparison
with healthy mothers and those with other mental disorders, schizophrenic mothers are more remote, self-absorbed, intrusive, flaccid,
insensitive and unresponsive, and less demanding when taking care
of their infants (McNeil et al., 1985; Näslund et al., 1985; PerssonBlennow et al., 1984, 1986; Riordan et al., 1999; Snellen et al., 1999;
Wan et al., 2007). The speech of mothers with schizophrenia is less
infant-focused, more negative, and with fewer songs and rhymes
(Wan et al., 2008). Their infants are more avoidant (Riordan et al.,
1999). One important contributing factor for the disrupted motherinfant interaction recognized by both patients and clinicians is antipsychotic medications (Awad, 1993; Awad and Hogan, 1994; Seeman,
2004). Animal work also finds that a variety of antipsychotics, from
typical (e.g., haloperidol) to atypical (e.g., clozapine, risperidone,
olanzapine and quetiapine), to even more recent novel antipsychotics (e.g., aripiprazole and amisulpride), possess a common disrup-

tive effect on active maternal responsiveness (e.g., pup retrieval, pup
licking, nest building) in postpartum rats. Acute administration of
typical and atypical antipsychotics disrupts pup retrieval, pup licking, and nest building but not nursing in postpartum female rats
(Giordano et al., 1990; Hansen et al., 1991a; Silva et al., 2001; Stern
and Keer, 1999; Stern and Taylor, 1991). Animals under the influence of antipsychotics are slower to approach pups and retrieve
fewer pups. They also spend less time licking their offspring and
building the nest (Li et al., 2004a). Furthermore, novel antipsychotics (e.g., amisulpride and aripiprazole) also exhibit a certain degree
of inhibition on active maternal responses in a dose-dependent fashion (Li et al., 2005a). Chronic treatment with haloperidol or olanzapine via mini-pumps or repeated daily injections significantly inhibits rat active maternal behavior as well (Li et al., 2005b). It seems that
the antipsychotic-induced disruption on pup retrieval, pup licking,
and nest building may be an inherent feature of all currently available antipsychotics.
Although the antipsychotic-induced disruption on rat active
maternal behavior is clear and robust, its underlying behavioral
mechanism is not. Since maternal behavior has motivational as well
as motor components, and given that antipsychotics (at least the typ-
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ical ones) are known to produce motivational and motoric impairments (Ikemoto and Panksepp, 1999; Salamone and Correa, 2002), it
raises the question of whether this disruptive effect is motivational
or simply motoric. In addition, because atypicals like clozapine and
quetiapine also give rise to sedation due to their actions on histamine H1 receptors and/or adrenergic receptors (Fleischhacker et al.,
1994), the atypical-induced disruption also could be attributed to
drug-induced sedation.
The present study was designed to further investigate the behavioral mechanisms underlying antipsychotic-induced disruption on
rat maternal behavior. To address the motivational versus motoric
issue, we employed a pup-separation technique. Previous studies
show that removing pups from dams for several hours (>3 h) prior
to maternal testing can significantly increase a mother rat’s maternal motivation (Hansen, 1994). Three to six hours of pup deprivation
can completely restore pup retrieval deficits induced by massive
DA depletion in the ventral striatum region in postpartum female
rats (Hansen, 1994). We treated our subjects with haloperidol and
clozapine and tested them under the pup-separation (4 h) and nopup-separation condition. If pup-separation is able to antagonize the
effect of antipsychotics, it would suggest that the disruptive drug
effect is mainly exerted on animals’ motivation rather than on their
motoric functions.
To examine to what extent antipsychotic drug-induced sedation contributes to their disruption on active maternal behavior,
we employed a repeated treatment schedule and compared effect
of antipsychotics with that of chlordiazepoxide, an anxiolytic drug
with a sedative effect (File, 1984). It is well known that with repeated
drug administration, the sedative effect of antipsychotics and anxiolytics is greatly diminished (Chesler and Salamone, 1996), and
tolerance can be seen with only four injections (File, 1984; Sanger,
1985). In the meantime, antipsychotic efficacy is progressively
enhanced with repeated drug administration (Agid et al., 2003; Li et
al., 2007). If drug-induced sedation plays a role in disrupting active
maternal behavior, we expect that the haloperidol- and clozapineinduced maternal behavior deficits would show an improvement
with repeated drug treatment. If this disruptive effect mainly reflects
the effect of dopamine blockade (Li et al., 2004a), the haloperidoland clozapine-induced deficits would persist and show a deterioration with repeated drug treatment.
2. Materials and methods
2.1. Subjects
Forty-six 2 or 3 month old pregnant female Sprague-Dawley rats
purchased from Charles River Inc. (Portage, MI) or mated at the colony were used in this study. All rats were housed individually in
48.3 cm × 26.7 cm × 20.3 cm transparent polycarbonate cages under
12-h light/dark conditions (light on between 6:30 am and 6:30 pm).
The temperature-controlled colony was maintained at approximately 23°C. Experiments were conducted during the light cycle.
The rats had free access to food and tap water in their home cages.
All animal procedures were conducted in accordance to the National
Institutes of Health Guide for the Care and Use of Laboratory Animals, and approved by the University of Nebraska Institutional Animal Care and Use Committee.
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cutaneously, whereas CDP was administered intraperitoneally. We
chose 0.1 mg/kg HAL and 10.0 mg/kg CLZ because these doses
have been shown to effectively disrupt active maternal behavior (Li
et al., 2004a). At the chosen doses, HAL and CLZ provided opamine
D2 receptor occupancies in animals comparable to those observed
in patients, approximately 50%-70% striatal D2 occupancy (Kapur et
al., 2003). Thus, this dose selection enabled us to evaluate different
drugs on a common ground at the clinically relevant dose. We also
included CDP as a pharmacological control. CDP, like atypical CLZ,
also gives rise to sedation (File, 1984) but lacks the antipsychotic
effect. We chose 5.0 mg/kg CDP because it is an effective anxiolytic
dose used in other behavioral models (Joordens et al., 1998; Klint,
1991; Li et al., 2004b) and more importantly, its sedative effect shows
a similar time course (File, 1984) to that of clozapine (Sanger,1985).
2.3. Basic experimental procedure
Starting 2 or 3 days prior to the first possible expected parturition
date, the subjects were monitored every morning for signs of parturition. Once the dam was found with pups in the morning (that day
was designated as Day 1 postpartum), the mother was transferred
into a clean cage with wood shavings for bedding. Two shredded
paper towels were also provided for nesting material. The litter was
culled to 8 pups (4 males and 4 females with the most visible milk
bands). Maternal behavior tests were conducted from Day 4 to 12
postpartum.
2.4. Maternal behavior test
Each test consisted of two phases. The first was a spot-check observation of maternal behavior under undisturbed condition. Using a
laptop computer with an event recording program (J Watcher, http://
www.jwatcher.ucla.edu/), we recorded the location of mother rats
and their pups and rated the quality of the nest on a 5-point scale
according to the criteria of Lonstein and Fleming (2002). The second
phase was an 8-min pup retrieval behavior test starting immediately
after the first undisturbed test. This phase was initiated by taking
the 8 pups away from the mother and destroying the nest. Ten seconds later, the pups were placed in the corner of the cage diagonal
to the nest site or dam sleeping corner. When the subject picked up a
pup in her mouth and carried it back to the nest site, it was referred
to as a successful pup retrieval. Approach latency was defined as the
time taken form other rats to approach and sniff the pups from the
reunion. First and last pup retrieval latency was defined as the time
elapsed from the first pup approach to the retrieval of the first and
eighth pup into the nest respectively. A score of 480 s was assigned to
non-responders who did not approach or retrieve the testing pups.
The total number of pups retrieved was recorded. The occurrence of
other behaviors was also recorded, including pup nursing behavior
(a rat positioning herself over the pups with legs splayed to accommodate the pups, including hover, high and low crouching over postures), pup licking (a female rat placing its tongue on the anogenital area and the rest of a pups body), nest building (a rat picking up
nesting material in her mouth and transporting it back to the nest
site or pushing the material with her forepaws toward the nest site).
After the test, any unretrieved pups were returned to the nest site.
The observers were unaware of the drug condition of each subject.

2.2. Drugs and choices of dosage

2.5. Experiment 1. Effects of pup-separation on the acute antipsychoticinduced maternal behavior deficits

The injection solutions of haloperidol (HAL, 5.0 mg/ml ampoules,
Sabex Inc., Boucherville, Quebec, Canada) and chlordiazepoxide
(CDP, Sigma-Aldrich, St. Louis, MO) were obtained by mixing the
drugs with sterile water. Clozapine (CLZ, a gift from NIMH drug
supply program) was dissolved in 1.0% glacial acetic acid in distilled water. HAL, CLZ, and vehicle water were administered sub-

Four groups of postpartum rats (HAL- 0.1 mg/kg, CLZ- 10.0 mg/
kg, CDP- 5.0 mg/kg, and vehicle water, n = 12 per group for HAL,
CLZ and vehicle; n = 10 for CDP) were used. On Day 4 postpartum,
the first maternal behavior test started 0.5 h before drug injections
(i.e., baseline). The second and third tests were carried out at 2 h and
4 h after the drug or vehicle injection. We performed across-over
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(change-over) trial with variants of the two-treatment, two-period
design. Half of the mother rats allocated at random to each group
(n = 6 for HAL, CLZ and vehicle; n = 5 for CDP) were tested under
the pup-separation condition in which their pups were taken away
from them 4 h before the second test on that day. Pups were placed
into a bowl with nesting material on a temperature-controlled heating pad (34°C). The other half of the mother rats were tested without
separation from their pups (no-pup-separation condition). On Day 6
postpartum, the same procedure was applied, but the rats started on
the pup-separation condition on Day 4 started on the no-pup-separation condition, and ones previously started on the no-pup-separation condition started on the pup-separation condition (a complete
counter balanced design). This cross-over design allowed us to consecutively test each subject which received two experimental manipulations during the course of the experiment. Various measures of
maternal behavior were recorded (see below for testing details).
2.6. Experiment 2. Effects of repeated antipsychotic treatment on maternal behavior in rats
The above four groups of postpartum rats were used in this experiment. After 2 days of rest, rats were treated with the same drug as
before and tested on Days 8, 10 and 12 postpartum. On each drug
test day, maternal behaviors were measured at 4 time points, with
the first one at 0.5 h before the drug injections (i.e., baseline), and the
rest at 1, 2, and 4 h after the drug injection. In addition to maternal
behavior tests, the characteristics of sedation (e.g., eye closed, head
down, curled up in a ball, flattened posture, ataxia, problems with
limb placement, lack of alertness, general appearance of sleepiness)
were concurrently observed. The sedative manifestations of mother
rats were further assessed for 30-sec periods according to a sedation
rating adapted from Chesler and Salamone (1996): 4 = awake, active:
engaged in locomotion, rearing or head movement; 3 = awake, inactive: eyes fully open, head up, no locomotion or rearing, normal
posture; 2 = moderate sedation: eyes partly closed, head somewhat
down; 1 = heavy sedation: eyes mostly closed, head mostly or entirely
down, flattened posture, lack of normal limb placement; 0 = asleep.
2.7. Data analysis
Data for most maternal behaviors were presented as mean ± SEM.
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To examine the acute and chronic treatment effects, data were
analyzed using a factorial repeated measures analysis of variance
(ANOVA) with the between-subject fact or being the treatment condition (HAL, CLZ, CDP and VEH) and the within-subject factors
being the testing time points (e.g. baseline, 1 h, 2 h and 4 h) or days
(Days 8, 10, and 12). Group differences were further investigated
using simple main effect tests (one-way ANOVA) followed by LSD
post hoc tests for multiple comparisons where appropriate. To examine the pup-separation effect, data from the Day 4 and Day 6 under
the same testing condition (e.g. pup-separation on Day 4 and Day 6)
were combined and analyzed using Paired-Samples T test.
For the latency and sedation data, because they were not normally
distributed (e.g. the cut-off time set at 480 s for the latency data,
and the sedation was ranking data), data for latency and sedation
were displayed as median ± interquartile range. Nonparametric
Kruskal-Wallis test was used for analyzing the difference between
the drug treatment groups. Once the overall significant effects were
determined, two-group comparisons between the drug and vehicle
treatment were performed using Mann-Whitney U test. Separation
effect was examined by comparing maternal behavior tested under
the pup-separation condition with that tested under the no-separation condition using Wilcoxon Two Related-Samples tests. Correlation between the disruptive effect on pup retrieval and sedation of
the drugs was tested using Spearman’s rank correlation analysis to
evaluate the possible influence of drug-induced sedation on maternal behavior. A conventional two-tailed level of significance at the
0.05 level was required.
3. Results
3.1. Experiment 1. Effects of pup-separation on the acute antipsychoticinduced maternal behavior deficits
3.1.1. Acute haloperidol and clozapine treatment impaired active components of maternal behavior
To identify the acute effect of antipsychotic treatment on maternal
behavior, we examined maternal behavior of the four groups tested
under the regular condition (no-pup-separation) on Day 4 postpartum (see Figure 1). Consistent with our previous report (Li et al.,
2004a), a single injection of HAL and CLZ, but not CDP significantly
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disrupted various active components of maternal behavior. Rats
treated with HAL and CLZ took a much longer time to approach and
retrieve their pups into the nest sites (data not shown) and retrieved
less pups at 2 h and 4 h testing points (all ps < 0.05). They also spent
less time on pup licking and nest building (One-way ANOVA and
LSD post hoc test, all ps < 0.05). However, nursing activity was not
significantly affected by any drug treatment. CDP only impaired
nest building (p < 0.01 for 2 h, p < 0.05 for 4 h), suggesting that this
behavior may be more vulnerable than others to the disruptive effect
of drug treatment.

Paired-Samples T test showed that separation significantly enhanactivity across all four groups at the 2 h post-injection testing point (p
< 0.01 for VEH, CDP; p < 0.05 for HAL, CLZ). It should be noted
that although we used the combined data to examine the effects of
pup-separation, the same results were obtained when the data from
Days 4 and 6 postpartum were not combined and analyzed separately.

3.1.2.Pup-separation shortened pup approach latency and increased pup
licking and pup nursing, but failed to reverse pup retrieval deficit
To examine the effects of pup-separation on maternal behavior
under the influence of antipsychotics, we compared the maternal
behavior data obtained under the pup-separation condition from
Days 4 and 6 postpartum with those obtained under the no-pupseparation condition from both days. Once again, in comparison
to the vehicle, HAL disrupted pup retrieval and CLZ inhibited the
dams’ approach and retrieval of their pups in this data set. Pup-separation significantly shortened CLZ-treated pup approach latency
(Table 1) but failed to alleviate the pup retrieval deficits, as there was
no significant improvement in the first and last pup retrieval latency
(Table 1) and in the number of pups retrieved (Figure 2A). Repeated
measures ANOVA on the number of pups retrieved revealed a significant main effect of drug treatment [F(3,42) = 14.58, p = 0.000 for 2 h;
F(3,42) = 11.68, p = 0.000 for 4 h], but no significant effect of separation
or interaction between the drug treatment and pup-separation. Pupseparation also did not affect the nest building activity (Figure 2C).
Repeated measures ANOVA revealed a main effect of drug treatment [F(3,42) = 28.64, p = 0.000 for 2 h; F(3,42) = 16.79, p = 0.000 for 4 h],
but no significant effect of separation or interaction between the two
factors.
Most prominently, pup-separation did substantially increase the
amount of time spent by the mothers on licking (Figure 2B) and nursing (Figure 2D). For pup licking, repeated measures ANOVA revealed
a main effect of drug treatment [F(3,42) = 6.43, p = 0.001], a significant
effect of separation [F(1,42) = 36.07, p < 0.001], and a significant interaction between the two factors [F(3,42) = 3.29, p = 0.030] at the 2 h testing
point. Two-group comparisons (or one-way ANOVA) revealed that
pup-separation consistently enhanced duration of pup licking across
all treatment groups at the 2 h point (p < 0.01 for VEH and CDP,
p < 0.05 for HAL and CLZ). For pup nursing, repeated measures
ANOVA revealed a significant effect of separation [F(1,42) = 32.03, p
= 0.000], but no main effect of drug treatment or significant interaction between the two factors at the 2 h point. Further analysis with

As can be seen in Figure 3, with repeated drug administration,
HAL progressively enhanced its disruption on pup retrieval and
maintained its disruption on pup approach, pup licking, and nest
building. In contrast, CLZ showed a progressively attenuated disruption on pup approach and retrieval but maintained its disruption
on pup licking and nest building.

3.2. Experiment 2. Effects of repeated antipsychotic treatment on maternal behavior in rats

3.2.1. Latency to approach and retrieve pups
With repeated drug administration, HAL produced persistent
disruption of the pup approach latency and the first and last pup
retrieval latency over 4 sessions across the three test days (data not
shown), whereas CLZ exerted this disruptive effect at 1 h and 2 h
(all p < 0.01) only on the first testing day. CDP treatment had no significant effect on pup approach and pup retrieval latency (data not
shown).
3.2.2. Pup retrieval
With repeated drug treatment, HAL progressively reduced the
number of pups retrieved, whereas the disruptive effects of CLZ
on this behavior were diminished. CDP had no significant effect in
this regard. Repeated measures ANOVA revealed a significant main
effect of drug treatment [F(3,40) = 4.16, p = 0.012 for baseline; F(3,40) =
10.17, p < 0.001 for 1 h; F(3,40) = 11.28, p < 0.001 for 2 h; F(3,40) = 8.64,
p < 0.001 for 4 h], no significant effect of test day, but a significant
interaction between the two factors [F(6,80) = 1.21, p = 0.031 for baseline; F(6,80) = 3.48, p = 0.004 for 1 h; F(6,80) = 7.06, p < 0.001 for 2 h; F(6,80)
= 4.00, p = 0.001 for 4 h]. Post hoc tests showed that HAL significantly
disrupted retrieval activity at 1 h, 2 h, and 4 h testing points (all ps <
0.05) across the test days, even at the baseline on Day 10 postpartum
(p = 0.030); whereas CLZ impaired pup retrieval at 1 h, 2 h, and 4 h
post-injection testing points (all ps < 0.05) only on Day 8 postpartum.
Additionally, Paired Samples T tests comparing the data on Day 8 to
Day 12 postpartum showed that with repeated drug administration,
the disruptive effect of HAL was progressively potentiated, whereas
CLZ showed a progressively attenuated disruption (all ps < 0.05).

Sedation and Disruption of Maternal Motivation Underlie the Disruptive Effects of Antipsychotic Treatment on Rat Maternal Behavior

3.2.3. Pup licking
Repeated measures ANOVA revealed a main effect of drug treatment [F(3,40) = 12.36, p < 0.001 for 1 h; F(3,40) = 17.80, p < 0.001 for 2
h], no significant effect of test time or significant interaction between
the two factors at 1 h or 2 h testing point. Post hoc tests showed that
HAL significantly impaired pup licking activity at 2 h post-injection
(both ps < 0.05), while CLZ did so at 1 h and 2 h on Day 10 and Day
12 postpartum (both ps < 0.05). As opposed to HAL and CLZ, CDP
produced a significant enhancing effect on pup licking at 1 h and 2
h testing points on Day 8 postpartum (both ps < 0.05). No long-term
potentiation or attenuation of the drug effect on pup licking activity
was observed (Paired Samples T test, Day 8 vs Day 12, all ps > 0.05).
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3.2.4. Nest building
Repeated measures ANOVA revealed a main effect of drug treatment (all ps < 0.001), no significant effect of test day, but a significant
interaction between the two factors (all ps < 0.05) at 1 h, 2 h, and 4
h testing points; there was a main effect of drug treatment [F(3,40)
= 12.27, p = 0.045], a significant effect of test time [F(2,80) = 6.57, p
= 0.002], but no significant interaction between the two factors at
the baseline level. Post hoc tests showed that HAL significantly disrupted nest building activity at 1 h, 2 h, 4 h testing points (all ps <
0.05) across the three test days, at the baseline on Day 10 (p = 0.013)
and Day 12 postpartum (p = 0.015); whereas CLZ impaired pup
retrieval at 1 h and 2 h across the test days (all ps < 0.05) and at 4 h
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ment [F(3,40) = 15.14, p < 0.001 for 1 h; F(3,40) = 7.02, p = 0.001 for 2 h; F(3,40)

(p = 0.014) on Day 8 postpartum only. In particular, CDP produced
a disruptive effect on this behavior similar but somewhat weaker
than that of HAL and CLZ (all ps < 0.05). Long-term potentiation
of the drug effect was observed (Day 8 vs Day 12 Paired Samples T
test, p< 0.05).
3.2.5. Pup nursing
Repeated measures ANOVA revealed a main effect of drug treat-

= 16.45, p = 0.019 for 4 h], a main effect of test time [F(2,80) = 4.11, p =
0.020 for 1 h; F(2,80) = 9.78, p < 0.001 for 2 h; F(2,80) = 4.78, p = 0.011 for
4 h], but no significant interaction between the two factors at 1 h, 2
h and 4 h testing points; there was a main effect of drug treatment
[F(3,40) = 3.21, p = 0.033] but no significant effect of test time or significant interaction between the two factors at the baseline level. Post
hoc tests showed that there were no consistent effects among the
different drug conditions on nursing activity (Figure 3D). The same
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drug produced an opposite effect at distinct test points or test days.

For instance, HAL increased duration of pup nursing at the 1 h testing point on Day 10 and Day 12 postpartum, as well as 2 h on Day
12 postpartum, whereas it suppressed this behavior at 4 h on Day 8
postpartum. Also, CLZ enhanced this activity at baseline on Day 12
postpartum but reduced it at 2 h on Day 10 postpartum. Noticeably,
CDP produced a prominent enhancing effect on the nursing behavior. Long-term potentiation of the drug effect was observed (Day 8
vs Day 12 Paired Samples T test, all ps < 0.05).
3.2.6. Repeated antipsychotic treatment induced an attenuated sedation
Figure 4 depicts the sedation scores of repeated treatment with
HAL, CLZ, CDP, and vehicle over the four test sessions each day
over the three test days. The sedative effect of HAL and CLZ tended
to diminish over the testing period, whereas CDP at the present dose
did not produce a noticeable sedation. Further analysis with MannWhitney U test showed that in comparison to the vehicle treatment,
HAL induced a mild sedative effect at the 2 h post-injection testing
point across the test days, whereas CLZ produced moderate sedation at 1 h and 2 h on Day 8, and at 2 h only on Day 10. Long-term
alleviation of the drug sedative effect was observed (Day 8 vs Day
12 Wilcoxon’s Two Related Samples Tests, all ps < 0.05). To examine
to what extent that drug-induced sedation may contribute to the disruption on maternal behavior, we assessed the correlation between
the disruptive effect of HAL and CLZ on the number of pups
retrieved as a representative parameter of active maternl behaviors
and the sedation scores of these drugs at the 2 h testing point from
Day 8 to 12. We chose the 2 h point as the representation of the drug
effect because the present and previous studies show that after a single injection of HAL and CLZ (Li et al., 2004a), the drug effects peak
at 1-2 h post-injection. Spearman rank correlation analysis revealed
that the disruptive effect of CLZ was strongly correlated with its sedative effect (Rs = 0.502, p = 0.002), whereas HAL-induced disruption
was not correlated with its sedation (Rs = 0.039, p = 0.830). These
results demonstrate that HAL-induced disruptive effect on active
maternal behavior (number of pups retrieved) is mainly attributable
to its effect of dopamine blockade but not sedation of the drug, but
CLZ’s sedative effect is at least in part responsible for CLZ-induced
disruption on this active maternal behavior.
4. Discussion
In the present study, we showed that acute and chronic treatment with HAL and CLZ disrupted active maternal behaviors
(e.g., pup retrieval, pup licking and nest building) in the postpartum female rats. More importantly, using the pup-separation technique, we found that separation of the pups from their
mothers for 4 h before testing significantly enhanced pup licking activity and stimulated nursing behavior, an effect most likely

attributable to the motivation-enhancing effect of pup-separation.
In addition, with the repeated drug treatment, we showed that HAL
progressively impaired active components of maternal responses
(e.g., pup approach, pup retrieval and nest building), while HALinduced sedation was diminished across the test period. In contrast, the magnitude of both the disruptive and sedative effects of
CLZ was reduced throughout the postpartum period, suggesting
that the CLZ-induced disruption in pup retrieval may be partially
attributed to its sedative side effect.
It is well documented that acutely administered antipsychotics
disrupt active maternal behavior in rats, but generally have little
effect, or even an enhancing effect on pup nursing (Giordano et al.,
1990; Li et al., 2004a; Silva et al., 2001; Stern and Taylor, 1991). However the exact behavioral mechanisms underlying such an effect are
not entirely clear. In the present study, we explored the possibility that antipsychotic-induced maternal behavior deficits may primarily reflect an inhibition on maternal motivation, an action that
is likely mediated by antipsychotics’ common antagonistic effect
on dopamine D2 receptors (Kapur and Mamo, 2003). Toward this
end, we employed a pup-separation technique because motherpup separation has been shown to enhance maternal motivation in
the postpartum rats (Hansen, 1994; Hansen et al., 1993). This idea
is based on the finding that separation of the lactating rats with
6-OHDA lesions in the ventral striatum from their pups for 3-6 h
shortened their pup retrieval latency (Hansen, 1994). We reasoned
that if pup-separation is able to antagonize the effect of dopamine
blockade of the antipsychotics, it would suggest that the disruptive
drug effect is mainly exerted on animals’ motivation rather than
on their motoric functions. To the best of our knowledge, there is
no study that has directly compared the effect of pup-separation
on the antipsychotic-induced maternal behavior deficits. We found
that pup-separation significantly shortened clozapine-elongated
approach latency, and increased pup licking in lactating dams, the
most frequently observed pup-directed active behavior (Lonstein et
al., 1999), while facilitating quiescent nursing activity (Stern, 1991;
Stern and Taylor, 1991). These findings strongly suggest that pupseparation is capable of reversing some maternal behavior deficits
to a certain extent, which in turn, indicates that antipsychotics may
disrupt maternal behavior by inhibiting mothers’ motivation to
take care of the young, not simply impairing their motor functions.
This point is also supported by the findings from Stern and Taylor (1991) and Li et al. (2004a). Stern and Taylor (1991) reported that
HAL at 0.2 mg/kg, a dose much higher than ours (HAL at 0.1 mg/
kg), did not produce any disruption of pup retrieval, whereas Li et
al. (2004a) found that it did. Our current study found that HAL even
at 0.1 mg/kg produced a significant impairment on pup retrieval
when rats were tested under the regular, no-pup-separation condition. One reason for this different result may lie in the fact that
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Stern and Taylor (1991) tested their rats under a 4-h mother-pup
separation condition, whereas Li et al. (2004a) tested rats under the
regular (no-pup-separation condition). The current finding showing that antipsychotic-treated rats responded to their pups differently under the separation and no-separation condition is consistent with this explanation.
Contrary to our results, a similar study using pup-separation
skill showed that demanding pups (pups that remained separated
from their mothers for 12 h before testing) significantly reversed all
the deficits of active components of maternal behaviors (e.g., pup
retrieval, mouthing, pup licking and nest building) in HAL-treated
lactating females (Pereira and Ferreira, 2006). The different effects
of pup-separation on HAL-induced maternal behavior impairments
between the two studies may be due to the methodological differences. These differences include the HAL dose (0.05 mg/kg vs 0.1
mg/kg), duration of separation (12 h vs 4 h), testing duration (30
min vs 8 min), etc. In addition, in that study, the mother rats were
not separated from their litters until 15 min before testing and were
tested with donor pups that were isolated for 12 h, whereas in this
present study, our subjects were separated from their own pups
and tested with their own pups. Taken together the findings from
both studies, it is interesting to speculate that a 12-h separation is
more effective in stimulating maternal motivation and overcoming
the impairments induced by a lower dose of HAL (0.05 mg/kg).
There are several possible factors associated with pup-separation
that may increase maternal motivation and contribute to the different maternal performance observed under the pup-separation and
no-separation condition. One possible factor is the increase of incentive value of separated pups. After an extended separation (~4 h),
pups are in acute need of active maternal care because they are hungry and they also need mothers to provide anogenital stimulation to
help them urinate and defecate (Brouette-Lahlou et al., 1992). Also,
separated pups may attract the mother rat’s attention by emitting
more audible and ultrasonic vocalizations (Brouette-Lahlou et al.,
1992; Hofer, 1973; Iijima and Chaki, 2005; Polan and Hofer, 1999).
Another possible factor is the change of physical condition of separated mothers. After a prolonged separation, milk engorgement of
the mammary glands in dams may stimulate mother rats to approach
to the sensory cues emitted by the pups and thereby increase their
maternal performance. Previous work has shown two to three minutes separation is less effective in improving pup retrieval than a
4-6 h separation because shorter separation doses not allow sufficient distention of mammary glands (Hansen, 1994). Moreover,
the degree of maternal responses to pups is found to be correlated
with duration of separation from pups (Hansen, 1994). Given that
dopamine plays an essential role in regulating maternal motivation through the mesolimbic dopamine system (Byrnes et al., 2002;
Hansen et al., 1991b; McCullough et al., 1993; Miller and Lonstein,
2005; Numan et al., 2005; Robbins and Everitt, 1996), it is conceivable that separation-facilitated pup licking may be associated with
an increase in mesolimbic dopamine release. This idea is consistent
with the finding that the increase in dopamine level in the nucleus
accumbens shell is significantly correlated with the magnitude and
duration of the licking bout (Champagne et al., 2004). This hypothesis is further supported by earlier studies showing that dopamine
receptor blockade in the nucleus accumbens disrupted pup licking
(Keer and Stern, 1999; Stern and Lonstein, 2001), and reunion with
separated pups significantly increases dopamine release in the ventral striatum of maternal rats (Hansen et al., 1993), and blockade of
dopamine neurotransmission by haloperidol decreases exploratory
behavior as measured by the reduced percentage of time spent in
the open arms of the maze, whereas the presence of the pups in the
open arms of the maze override such deficits provoked by haloperidol (Pereira et al., 2005).
In contrast to our expectation, pup-separation failed to reverse
the antipsychotic-induced disruption of pup retrieval. We often
observed that after reunion with the pups, the vehicle-treated rats
rapidly approached and retrieved the pups into the nest site then

in

Pharmacology, Biochemistry

and

B e h a v i o r 92 (2009)

started to lick the pups while adopting a hovering posture over the
pups. However, for the antipsychotic-treated rats, after the pups
were placed into the test cages, the dams often promptly commenced to lick them at the corner where the pups were placed, failed
to retrieve them back to the nest site. This may explain why pup-separation had less of an effect on reversing the pup retrieval deficitinduced by antipsychotic treatment. We also failed to observe any
effect of pup-separation on antipsychotic-induced disruption in nest
building. During the 8-min pup retrieval session, we noted that after
reunion with the pups, the mother rats spent most of their time on
retrieving, licking and nursing pups, and spent less time on rebuilding the nest. The disrupted nest building behavior is not so easy to be
restored relative to pup licking and pup retrieval is consistent with
our previous observation that nest building activity is one component of rat maternal behavior most sensitive and vulnerable to pharmacological disturbance (Li et al., 2004a, 2005a; Silva et al.,2001).
To address whether and to what extent antipsychotic drug-induced
sedation is associated with their disruption on active maternal
behavior, we employed a repeated treatment regimen and recorded
the sedation scores along with maternal performance. We also compared the effects of HAL and CLZ with CDP, an anxiolytic drug with
sedative effect. Because sedation tends to dissipate with repeated
drug treatment (Chesler and Salamone, 1996; File, 1984; Salamone
et al., 1996), we reasoned that if it is a contributing factor, we would
expect to see more severe disruption on maternal behavior at the
early stage of testing than the later. Data from Days 8, 10 and 12 postpartum indicate that with repeated drug administration, HAL and
CLZ produced differential pattern of drug effect on active maternal behavior. HAL induced a sustained disruption on active component of maternal behavior throughout the drug treatment period in
the background of a diminished seative effect. This observation discounts the sedation explanation for the disruptive effect of HAL. For
CLZ, we found that both its disruptive effect on maternal behavior
(e.g. pup retrieval) and its sedative effect were attenuated with the
repeated drug administration and there was a significant correlation
between the two, suggesting the CLZ-induced sedation may contribute to its disruptive effect on maternal behavior. It should be noted
that animals used in the repeated treatment test were not experimentally or pharmacologically naïve at the start of the experiment. We
could not rule out the potential carry-over effects produced by the
previous drug administration or separation manipulation. There is a
possibility that unmanipulated and drug-naïve animals would have
had somewhat different behavioral profiles in Experiment 2. Future
work using naïve animals and testing them for more days may help
answer this question.
In the present study, we chose CDP as a pharmacological control to examine the specificity of antipsychotics’ effect on maternal
behavior. CDP, similar to atypical CLZ, also gives rise to sedation
(File, 1984) but lacks the antipsychotic effect. We hypothesize that
if the disruptive effect on maternal motivation is specific to antipsychotic drugs, we expect that CDP would not significantly disrupt active maternal behaviors but produce sedative effect to some
extent. Surprisingly, we were unable to detect evident sedation
induced by CDP at 5.0 mg/kg, while others have shown it does (File,
1984). One possible explanation for the discrepancy may be due to
methodological difference. In the previous work, the sedative effect
of CDP was assessed by quantifying locomotor activity and exploration (File, 1984), while we measured sedation according to a sedation rating (Chesler and Salamone, 1996) in which locomotor activity
and exploration were not quantitatively analyzed. We cannot completely exclude the possibility of reduced locomotor activity and
exploration after CDP treatment, if any, in the present study as previously observed by File (1984). Another reason for the discrepancy
may be the different subjects used in the two studies. Of note, lactating rats were used in the present study as opposed to male animals
in the previous work. Reduced emotional and neuroendocrine stress
responses such as reduced anxiety and fear have been described in
lactation (Neumann et al., 2000; Windle et al., 1997). It is possible that
the reduced anxious and fearful responses may make the lactating
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subjects less sensitive to the anxiolytic drugs (e.g., CDP). Earlier evidence in favor of this view came from the findings that the anti-anxiety effect of a serotonergic agonist, 8-hydroxy-2 (di-n-propylamino)
tetralin (8-OH-DPAT) were completely absent in 7-day lactating rats
(Fernández-Guasti et al., 1998; Picazo et al., 2000). Further study is
needed to address this issue and determine whether CDP induces
sedation in lactating rats and if it does, whether this sedative effect is
less severe in lactating rats than male rats.
Finally, the relation between motor function and motivational processes is an additional point to consider in the present work. Because dopamine is closely associated with motor
and motivational functions, and motor activity is an important feature of motivated behavior (Salamom ,ne, 1987, 1988),
it is somewhat difficult to draw a hard and fast line between motor
and motivational systems in the brain. It has been argued that the
motor and motivational processes overlap considerably and share
some common mechanisms of regulation (Salamone, 1987, 1988,
1991, 1992; Salamone et al., 1989). In support of this view, our data
reveal that some impairments of active maternal behavior are more
easily reversible (e.g., pup licking), while others are not (e.g., nest
building), suggesting that not all the motivated behaviors impaired
by HAL and CLZ are equally restored with motivational manipulations (pup-separation).
In summary, the present study shows that the disruptive effect
of antipsychotics on maternal behavior at least in part reflects its
suppressive effect on maternal motivation as pup-separation significantly increases pup licking activity, one active component of
maternal motivation. In addition, our repeated drug testing data
also reveal that CLZ’s sedative effect is also involved in its disruptive effect on maternal behavior. The fact that CDP did not impair
maternal behavior except nest building suggests that antipsychoticinduced deficits may reflect a common effect of dopamine blockade
(Li et al., 2004a). These findings suggest that behavioral techniques
aimed at increasing maternal motivation may help alleviate the negative side effects of antipsychotic treatment on maternal behavior.
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